2020-09-17

[#DIV28SUPER] UK SURE 2021

Dear Colleagues-


Please find attached a save the date for the annual University of Kentucky Substance Use Research Event (SURE; formerly Substance Use Research Day) to be held on March 3rd, 2021, at the Gatton Student Center in Lexington, KY.  Please share the save the date information with interested trainees and colleagues--we welcome attendees from out of town!

 

SURE 2021 will include keynote plenary presentations from Dr. Yasmin Hurd and Dr. Magdalena Cerd√°. Dr. Hurd is the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute at the Icahn School of Medicine at Mount Sinai in New York City. Dr. Cerd√° is an Associate Professor and Director of the Center for Opioid Epidemiology and Policy at the Department of Population Health at NYU Grossman School of Medicine. Thematic symposia are planned that address timely and important health issues, including COVID-19 and SUD, health disparities in addiction/addiction treatment, and policy issues that impact access to care and provision of optimal care. A T32 trainee data blitz is also planned.

 

The Organizing Committee is also exploring options for hybrid meeting formats should the COVID-19 pandemic continue to impact professional meetings and gatherings. You may provide feedback on your preferences for meeting format using the survey link on the attached save the date. Registration and abstract submission links are also active and can be found on the attachment.

 

The full SURE announcement will follow in mid-October-- we look forward to seeing everyone there!


-UK SURE Organizing Committee (Christal Badour, Chris Delcher, Pavel Ortinski, Bill Stoops and Hilary Surratt)



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383


Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science
Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2020-09-16

[#DIV28SUPER] Graduate Student Opportunities at the Indiana University School of Public Health-Bloomington

We are pleased to share that we are recruiting students for our PhD program in Health Behavior for fall 2021. Our program offers outstanding training for individuals interested in pursuing careers in public health research. We are especially looking for students with interests in—among other areas—the causes, prevention, and treatment of substance use problems, chronic pain, and related mental health conditions.

 

Our school has embarked on a period of rapid growth in faculty and research, in part through Indiana University's Responding to the Addictions Crisis Grand Challenge. This ambitious university-wide research initiative seeks to prevent and reduce the public health impact of opioid use and other addictive behaviors. Now is an exciting time to join us!

 

Available New Addictions Faculty Mentors in the Health Behavior Program

Dr. Kit Elam studies longitudinal genetic and environmental influences on adolescent and adult psychopathology and substance use (alcohol, marijuana, illicit drugs). His work focuses on how parenting and peer relationships in childhood and adolescence serve as risk and resilience factors for substance use, and their interplay with genetic influences. He studies these processes using longitudinal studies and methods spanning infancy to adolescence, and adolescence to adulthood. For more information, see here: https://go.iu.edu/34qt

 

Dr. Alison Greene studies how intervention design and implementation impact substance use and sexual health outcomes for adolescents, and how systems can improve conditions to support protective factors, impact health determinants, and decrease risk factors among adolescents and their families. She utilizes CBPR, mixed method designs, and translational science to conduct community-engaged adolescent health intervention research. For more information, see here: https://go.iu.edu/37pz

 

Dr. Patrick Quinn studies the causes and consequences of substance use. His interests range across substances (e.g., from cigarette smoking to opioids) and across the lifespan (e.g., from prenatal drug exposure to medication treatment for adults with ADHD). In particular, much of his research examines pain and its treatment with opioid medications, using longitudinal studies and methods from epidemiology and behavioral genetics. For more information, see here: https://go.iu.edu/35Ez

 

Our Program: The PhD program in Health Behavior helps students pursue rigorous research to address today's most pressing public health issues (https://publichealth.indiana.edu/academics/doctoral/phd-health-behavior/index.html). You will work with fellow outstanding students and an award-winning faculty in a versatile department that emphasizes the study of the promotion of health and the prevention of health problems. The program offers a breadth of opportunities for research, teaching, coursework, and professional development (https://bulletins.iu.edu/iub/phb/2019-2020/graduate/doctoral/health-behavior.shtml).

 

Incoming students will receive a competitive funding package including a stipend, health insurance, and tuition remission.

 

Located in beautiful Bloomington, IN, the Health Behavior program is housed in the Department of Applied Health Science of the Indiana University School of Public Health, a top-50 US school of public health.

 

How to Apply: Prospective students are highly encouraged to communicate with Drs. Elam, Greene, or Quinn to confirm a match of research interests before applying. A master's degree is required, and students should demonstrate an interest in a research-involved career, as well as evidence of research experience or potential. To receive priority consideration, please apply by January 15, 2021.

2020-09-14

[#DIV28SUPER] Assistant Professor Position at Auburn University

Please see the attached for a new position in the Cognitive and Behavioral Sciences program at Auburn University. Feel free to contact me with any questions.

 

--------------------------------------------------------------------------
Chris Newland, Ph. D.

Professor, Psychology and Neuroscience                          

226 Thach Hall 

342 West Thach Ave      
Auburn University

Alabama 36849-5212
Office: 334 844-6479       Fax:     334 844-4447
https://cla.auburn.edu/psychology/people/professorial-faculty/chris-newland/

---------------------------------------------------------------------------

 

2020-09-11

[#DIV28SUPER] NIDA Career Symposium=?Windows-1252?Q?=97Save_?=the Date, Monday, November 9, 2020

SAVE THE DATE:

Calling All Predoctoral, Postdoctoral, and Early Stage Investigators interested in NIH Grants and Drug Addiction Research!!

 

We miss you! As you know, various scientific meetings have recently been cancelled or postponed, which has resulted in the cancellation of the research training and career development workshops that the National Institute on Drug Abuse (NIDA) normally hosts at these scientific venues.  In order to provide that critical information to all addiction scientists and address your questions, we invite you to a virtual NIDA Career Workshop on November 9, 2020

 

This workshop will include an introduction from the NIDA Director, Dr. Nora Volkow; presentations on NIDA/NIH Training, Career Development and Diversity funding opportunities; and breakout sessions that will further discuss and answer specific questions relevant to the stage of your career.

 

This is a great opportunity for early-stage investigators to connect with NIDA program staff to learn about all the various funding awards and opportunities supported by NIDA, as well as whom to contact when you have questions about NIDA grants in the future.

 

For now, please mark your calendar and plan to join us on…

Monday, November 9th, 1:00 to 5:00 PM

 

More information and registration links coming soon!

 

Please let us know if you have any questions by contacting our NIDA Training and Career Development email address:  NIDA_Training@nida.nih.gov 

 

NIDA Career Workshop Team--

Beth Babecki

Roger Sorensen

Roger Little

Lindsey Friend

Albert Avila

Wilson Compton

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-

 

 

 

2020-09-08

[#DIV28SUPER] Postdoc in Translational Science of Alcohol and HIV at the University of Florida

Dear Colleagues and Students,

We are happy to announce that we can accommodate an entirely remote experience in the postdoctoral fellowship program described below. Please circulate to candidates who may be a match in terms of research interests for whom relocating may not be feasible at this time. Please do not hesitate to reach out to me, the other co-directors, Dr. Robert Cook (cookrl@ufl.edu) or Robert Lucero (rlucero@ufl.edu) or T32 administrator Dr. Frank (cafrank@ufl.edu). Further information can be found at sharc-research.org/training/t32-training/


Prior background in both HIV and alcohol research is NOT required. A background in the addictions or HIV/sexual health research with willingness to learn in the other area is more than sufficient.

All appointments to this training grant are restricted to U.S. citizens, legal permanent residents of the U.S. and noncitizen nationals. Persons on temporary or student visas are not eligible.

Best,

Rob Leeman


Robert F. Leeman, Ph.D.
Associate Professor
Mary F. Lane Endowed Professor
Department of Health Education and Behavior College of Health and Human Performance Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection Associate Director, Southern HIV & Alcohol Research Consortium (SHARC) University of Florida Florida Gymnasium, Room 14
PO Box 118210     Gainesville, FL  32611
Phone: (352) 294-1808
Email: robert.leeman@ufl.edu
Webpage: http://hhp.ufl.edu/about/faculty-staff/leeman_robert/

Twitter: @LeemanRobertF




UNIVERSITY OF FLORIDA - TRANSLATIONAL SCIENCE TRAINING TO REDUCE THE IMPACT OF ALCOHOL ON HIV INFECTION

OPENING FOR POSTDOCTORAL FELLOW IN T32 TRAINING PROGRAM


Multidisciplinary training program focused on:
- Alcohol and HIV
- Behavioral and clinical interventions
- Data science
- Neurocognition and brain science


Postdocs will work on NIH-funded grants, participate in seminars and training programs, develop their own research programs and be mentored by outstanding faculty including Co-Directors Drs. Robert Cook, Robert Leeman and Robert Lucero and from a wide variety of disciplines.

Funding includes an annual stipend, research/travel expenses and health insurance.
Individuals from under represented populations are strongly encouraged to apply.

Email questions & CV to sharct32@phhp.ufl.edu or any program faculty. Please see sharc-research.org/training/t32-training/

 

2020-09-04

[#DIV28SUPER] NIDA NeuroScience Update September 4, 2020

Table of Contents

I.                     NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed) RFA-AT-21-003

II.                   Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) NIDA Funding Opportunities PAR-20-225 for Early Stage Investigators

III.                 Other NIDA Funding Opportunities https://www.drugabuse.gov/funding/nida-funding-opportunities

 

I.           NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)  RFA-AT-21-003

Letter of Intent Due Date:  November 18, 2020

Application Due Date: December 18, 2020  by 5:00 PM local time of applicant organization.

 

he NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see http://neuroscienceblueprint.nih.gov/).

The goal of this FOA is to enhance our fundamental understanding of interoception with a specific focus on dissecting and determining the function of neural circuits that connects peripheral organs/tissues with the central nervous system (CNS) via peripheral ganglia. For this FOA, interoception science includes studies of the processes by which an organism senses, interprets, integrates, and regulates signals originating from within itself. This FOA encourages projects that combine diverse expertise and use innovative approaches to delineate interoceptive mechanisms at the molecular, cellular, circuitry, functional, and/or behavioral levels. Outcomes of this research will lay a critical foundation for future translational and clinical research on interoception as well as its roles in nervous system disorders. Studies of interoceptive neural circuits exclusively within the CNS may be more appropriate for The BRAIN Initiative funding opportunities. Applications in response to this FOA should budget for an annual investigator meeting organized by the NIH Blueprint for Neuroscience Research. Human subject research is not allowed for this FOA.  (For more details and instructions please read the entire funding opportunity Announcement).

II.        Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) NIDA Funding Opportunities PAR-20-225 for Early Stage Investigators

Application due date: October 19, 2020  by 5:00 PM local time of applicant organization.

Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.

The Genetics or Epigenetics of Substance Use Disorders Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics of substance use disorders. Frequently Asked Questions (FAQ).  (For more details and instructions please read the entire funding opportunity Announcement).

III.      Other NIDA Funding Opportunities

-----------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-

2020-09-03

[#DIV28SUPER] COVID-19 impact on drug use and mental health anonymous online survey

Greetings All,

Some colleagues and I from the Johns Hopkins Behavioral Pharmacology Research Unit have created a cross-sectional anonymous online survey on drug use patterns and mental health during COVID-19, which can be found at https://jhmi.co1.qualtrics.com/jfe/form/SV_0qXRpDkwZ5PLHIV

The study is gathering data from a convenience sample using word of mouth recruitment, so please feel free to complete yourselves, and/or distribute widely if you have any networks that might be interested. The survey takes about 20 minutes to complete and there is no compensation for participating. Happy to answer any other questions as needed.

Thanks!!

Al
 
--
Albert Garcia-Romeu, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
Phone: (410) 550-1972

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28